
Shanghai Junshi Biosciences Co., Ltd.
SSE:688180.SS
35.74 (CNY) • At close June 16, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Shanghai Junshi Biosciences Co., Ltd. |
Symbool | 688180.SS |
Munteenheid | CNY |
Prijs | 35.75 |
Beurswaarde | 32,483,630,179 |
Dividendpercentage | 0% |
52-weken bereik | 23.08 - 39.03 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ning Li |
Website | https://www.junshipharma.com |
An error occurred while fetching data.
Over Shanghai Junshi Biosciences Co., Ltd.
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclonal antibody under the trade name
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)